Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jorgenson

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 18, 2021
Conversion from cytomegalovirus universal prophylaxis with valganciclovir to the preemptive monitoring approach to manage leukopenia after kidney or pancreas transplantationMargaret R Jorgenson, Cynthia Wong, Jillian L Descourouez, et al.
Kidney International Reports|December 11, 2020
Serum Albumin Level Before Kidney Transplant Predicts Post-transplant BK and Possibly Cytomegalovirus InfectionAniruddha Srivastava, Joshua Bodnar, Fauzia Osman, et al.
The Annals of Pharmacotherapy|October 28, 2023
Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant RecipientsJillian L Descourouez, Jeannina A Smith, Christopher M Saddler, et al.
Pharmacotherapy|July 13, 2017
Ganciclovir-Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the LiteratureKatherine E Rolling, Margaret R Jorgenson, Jillian L Descourouez, et al.
Clinical Transplantation|April 28, 2025
De Novo Letermovir for Cytomegalovirus Prophylaxis in High-Risk Liver Transplant RecipientsHanna L Kleiboeker, Jillian L Descourouez, Chris M Saddler, et al.
Clinical Transplantation|June 15, 2026
Improved Tolerability of De Novo Letermovir Over Valganciclovir for Cytomegalovirus Prophylaxis in Seropositive Liver Transplant RecipientsHanna L Kleiboeker, Jillian L Descourouez, Chris M Saddler, et al.
The Annals of Pharmacotherapy|September 21, 2018
Management of Tumor Necrosis Factor α Inhibitor Therapy After Renal Transplantation: A Comparative Analysis and Associated OutcomesCaroline S Quinn, Margaret R Jorgenson, Jillian L Descourouez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 29, 2019
Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single-center retrospective studyStacey Rolak, Sarah Di Bartolomeo, Margaret R Jorgenson, et al.
The Annals of Pharmacotherapy|April 30, 2019
Safety of Antithymocyte Globulin in Patients Undergoing Liver Transplantation With Livers From Donation After Circulatory Death DonorsMargaret R Jorgenson, Jillian L Descourouez, Daniel C Felix, et al.
Clinical Transplantation|January 30, 2020
Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Beini Lyu, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 18, 2021
Conversion from cytomegalovirus universal prophylaxis with valganciclovir to the preemptive monitoring approach to manage leukopenia after kidney or pancreas transplantationMargaret R Jorgenson, Cynthia Wong, Jillian L Descourouez, et al.
Kidney International Reports|December 11, 2020
Serum Albumin Level Before Kidney Transplant Predicts Post-transplant BK and Possibly Cytomegalovirus InfectionAniruddha Srivastava, Joshua Bodnar, Fauzia Osman, et al.
The Annals of Pharmacotherapy|October 28, 2023
Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant RecipientsJillian L Descourouez, Jeannina A Smith, Christopher M Saddler, et al.
Pharmacotherapy|July 13, 2017
Ganciclovir-Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the LiteratureKatherine E Rolling, Margaret R Jorgenson, Jillian L Descourouez, et al.
Clinical Transplantation|April 28, 2025
De Novo Letermovir for Cytomegalovirus Prophylaxis in High-Risk Liver Transplant RecipientsHanna L Kleiboeker, Jillian L Descourouez, Chris M Saddler, et al.
Clinical Transplantation|June 15, 2026
Improved Tolerability of De Novo Letermovir Over Valganciclovir for Cytomegalovirus Prophylaxis in Seropositive Liver Transplant RecipientsHanna L Kleiboeker, Jillian L Descourouez, Chris M Saddler, et al.
The Annals of Pharmacotherapy|September 21, 2018
Management of Tumor Necrosis Factor α Inhibitor Therapy After Renal Transplantation: A Comparative Analysis and Associated OutcomesCaroline S Quinn, Margaret R Jorgenson, Jillian L Descourouez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 29, 2019
Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single-center retrospective studyStacey Rolak, Sarah Di Bartolomeo, Margaret R Jorgenson, et al.
The Annals of Pharmacotherapy|April 30, 2019
Safety of Antithymocyte Globulin in Patients Undergoing Liver Transplantation With Livers From Donation After Circulatory Death DonorsMargaret R Jorgenson, Jillian L Descourouez, Daniel C Felix, et al.
Clinical Transplantation|January 30, 2020
Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Beini Lyu, et al.
Pageof 8